Ortho Development Gains FDA Clearance on Trivicta Hip

Ortho Development received 510(k) clearance to market the Trivicta Hip System. The triple-taper femoral stem facilitates an optimal fit within the canal for a diverse range of patient anatomies.

Limited U.S. launch will commence in 2Q24, with full commercial release to follow.

Designed for initial and long-term stability, Trivicta boasts a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us